Dendritic cell based vaccine - CellxLife
Latest Information Update: 12 Jul 2024
At a glance
- Originator CellxLife
- Class Antineoplastics; Cancer vaccines; Dendritic cell vaccines; Immunotherapies
- Mechanism of Action Dendritic cell stimulants; Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase I Ewing's sarcoma; Osteosarcoma